 (4.3%), and
agranulocytosis (4.3%). No death was related to calcium
dobesilate administration. The authors concluded that
the adverse events’ risk with calcium dobesilate is low
despite 13 known cases of agranulocytosis in patients
treated by calcium dobesilate.
Clinical beneﬁt of horse chestnut extract.
Rationale. Horse chestnut extract contains escin, a
mixture of tr